Innate Pharma
IPHA
NZ$3.00
Share price
0.00%
Change (1 day)
-7.52%
Change (1 year)
Categories
Innate Pharma (IPHA) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : NZ$0.17 Billion
According to Innate Pharma 's latest financial reports the company's total liabilities are NZ$0.17 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Innate Pharma - Total liabilities on balance sheet (from 2009 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | NZ$0.23 B | -10.95% |
| 2022-12-31 | NZ$0.25 B | -2.14% |
| 2021-12-31 | NZ$0.26 B | 2.79% |
| 2020-12-31 | NZ$0.25 B | -15.62% |
| 2019-12-31 | NZ$0.30 B | -36.83% |
| 2018-12-31 | NZ$0.48 B | 69.56% |
| 2017-12-31 | NZ$0.28 B | -3.74% |
| 2016-12-31 | NZ$0.29 B | -20.59% |
| 2015-12-31 | NZ$0.37 B | 1398.49% |
| 2014-12-31 | NZ$24.93 M | -4.86% |
| 2013-12-31 | NZ$26.2 M | -34.62% |
| 2012-12-31 | NZ$40.08 M | -28.05% |
| 2011-12-31 | NZ$55.71 M | 122.96% |
| 2010-12-31 | NZ$24.98 M | -25.9% |
| 2009-12-31 | NZ$33.72 M | -28.29% |
| 2008-12-31 | NZ$47.02 M | 82.11% |
| 2007-12-31 | NZ$25.82 M | 6.99% |
| 2006-12-31 | NZ$24.13 M | 196.23% |
| 2005-12-31 | NZ$8.14 M |